Cargando…

Assessment of the Prevalence and Level of Awareness of Medication Overuse Headache Among the General Population in Makkah City, Saudi Arabia

Background: Medication overuse headache (MOH) is a secondary headache condition caused by consistently using more medication than necessary to treat headache symptoms. MOH is defined as a headache that occurs for 15 or more days per month in a patient with a pre-existing primary headache, and it dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Alharbi, Abdullah S, Alharbi, Omar F, Qutub, Fadi L, Albogami, Warif M, Aljuhnie, Mohammed A, Alharbi, Abdullah E, Alqahtani, Wed N, Babateen, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202447/
https://www.ncbi.nlm.nih.gov/pubmed/37223197
http://dx.doi.org/10.7759/cureus.37985
_version_ 1785045439942230016
author Alharbi, Abdullah S
Alharbi, Omar F
Qutub, Fadi L
Albogami, Warif M
Aljuhnie, Mohammed A
Alharbi, Abdullah E
Alqahtani, Wed N
Babateen, Omar
author_facet Alharbi, Abdullah S
Alharbi, Omar F
Qutub, Fadi L
Albogami, Warif M
Aljuhnie, Mohammed A
Alharbi, Abdullah E
Alqahtani, Wed N
Babateen, Omar
author_sort Alharbi, Abdullah S
collection PubMed
description Background: Medication overuse headache (MOH) is a secondary headache condition caused by consistently using more medication than necessary to treat headache symptoms. MOH is defined as a headache that occurs for 15 or more days per month in a patient with a pre-existing primary headache, and it develops as a result of regular overuse of symptomatic headache medication for more than three months. Patients with headaches often use simple pain medication for 15 or more days per month (e.g., non-steroidal anti-inflammatory drugs (NSAIDs) and paracetamol) and 10 or more days per month of opioids, triptans, and combination analgesics, but when there is no relief from these medications, the headache progression can lead to a cycle of consuming more medication with increased pain, which can lead to MOH. Objective: This study aimed to assess the prevalence and awareness of MOH among the general population of Makkah, Saudi Arabia. Methods: A cross-sectional study was conducted between December 2022 and March 2023 using a self-administered online questionnaire disseminated through social media. Data were collected from females and males 18 years of age and older living in Makkah, Saudi Arabia. Results: Overall, 715 individuals completed the questionnaire, 497 of whom were female (69.5%). The average age of the participants was 32.9 years (±13.3 years). The prevalence of MOH among those who reported having experienced headaches throughout their lifetimes was estimated to be 4.5%. Only 134 people (18.7%) were determined to be aware of MOH. Conclusion: This study demonstrated that the general population of Makkah has a high prevalence of MOH and low levels of MOH awareness.
format Online
Article
Text
id pubmed-10202447
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-102024472023-05-23 Assessment of the Prevalence and Level of Awareness of Medication Overuse Headache Among the General Population in Makkah City, Saudi Arabia Alharbi, Abdullah S Alharbi, Omar F Qutub, Fadi L Albogami, Warif M Aljuhnie, Mohammed A Alharbi, Abdullah E Alqahtani, Wed N Babateen, Omar Cureus Family/General Practice Background: Medication overuse headache (MOH) is a secondary headache condition caused by consistently using more medication than necessary to treat headache symptoms. MOH is defined as a headache that occurs for 15 or more days per month in a patient with a pre-existing primary headache, and it develops as a result of regular overuse of symptomatic headache medication for more than three months. Patients with headaches often use simple pain medication for 15 or more days per month (e.g., non-steroidal anti-inflammatory drugs (NSAIDs) and paracetamol) and 10 or more days per month of opioids, triptans, and combination analgesics, but when there is no relief from these medications, the headache progression can lead to a cycle of consuming more medication with increased pain, which can lead to MOH. Objective: This study aimed to assess the prevalence and awareness of MOH among the general population of Makkah, Saudi Arabia. Methods: A cross-sectional study was conducted between December 2022 and March 2023 using a self-administered online questionnaire disseminated through social media. Data were collected from females and males 18 years of age and older living in Makkah, Saudi Arabia. Results: Overall, 715 individuals completed the questionnaire, 497 of whom were female (69.5%). The average age of the participants was 32.9 years (±13.3 years). The prevalence of MOH among those who reported having experienced headaches throughout their lifetimes was estimated to be 4.5%. Only 134 people (18.7%) were determined to be aware of MOH. Conclusion: This study demonstrated that the general population of Makkah has a high prevalence of MOH and low levels of MOH awareness. Cureus 2023-04-22 /pmc/articles/PMC10202447/ /pubmed/37223197 http://dx.doi.org/10.7759/cureus.37985 Text en Copyright © 2023, Alharbi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Family/General Practice
Alharbi, Abdullah S
Alharbi, Omar F
Qutub, Fadi L
Albogami, Warif M
Aljuhnie, Mohammed A
Alharbi, Abdullah E
Alqahtani, Wed N
Babateen, Omar
Assessment of the Prevalence and Level of Awareness of Medication Overuse Headache Among the General Population in Makkah City, Saudi Arabia
title Assessment of the Prevalence and Level of Awareness of Medication Overuse Headache Among the General Population in Makkah City, Saudi Arabia
title_full Assessment of the Prevalence and Level of Awareness of Medication Overuse Headache Among the General Population in Makkah City, Saudi Arabia
title_fullStr Assessment of the Prevalence and Level of Awareness of Medication Overuse Headache Among the General Population in Makkah City, Saudi Arabia
title_full_unstemmed Assessment of the Prevalence and Level of Awareness of Medication Overuse Headache Among the General Population in Makkah City, Saudi Arabia
title_short Assessment of the Prevalence and Level of Awareness of Medication Overuse Headache Among the General Population in Makkah City, Saudi Arabia
title_sort assessment of the prevalence and level of awareness of medication overuse headache among the general population in makkah city, saudi arabia
topic Family/General Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202447/
https://www.ncbi.nlm.nih.gov/pubmed/37223197
http://dx.doi.org/10.7759/cureus.37985
work_keys_str_mv AT alharbiabdullahs assessmentoftheprevalenceandlevelofawarenessofmedicationoveruseheadacheamongthegeneralpopulationinmakkahcitysaudiarabia
AT alharbiomarf assessmentoftheprevalenceandlevelofawarenessofmedicationoveruseheadacheamongthegeneralpopulationinmakkahcitysaudiarabia
AT qutubfadil assessmentoftheprevalenceandlevelofawarenessofmedicationoveruseheadacheamongthegeneralpopulationinmakkahcitysaudiarabia
AT albogamiwarifm assessmentoftheprevalenceandlevelofawarenessofmedicationoveruseheadacheamongthegeneralpopulationinmakkahcitysaudiarabia
AT aljuhniemohammeda assessmentoftheprevalenceandlevelofawarenessofmedicationoveruseheadacheamongthegeneralpopulationinmakkahcitysaudiarabia
AT alharbiabdullahe assessmentoftheprevalenceandlevelofawarenessofmedicationoveruseheadacheamongthegeneralpopulationinmakkahcitysaudiarabia
AT alqahtaniwedn assessmentoftheprevalenceandlevelofawarenessofmedicationoveruseheadacheamongthegeneralpopulationinmakkahcitysaudiarabia
AT babateenomar assessmentoftheprevalenceandlevelofawarenessofmedicationoveruseheadacheamongthegeneralpopulationinmakkahcitysaudiarabia